GlaxoSmithKline hunts agency to promote weight-loss drug in Europe

By Kunal Dutta,, Friday, 16 November 2007 12:00AM

GlaxoSmithKline has kicked off a search for Alli - a US over-the-counter weight-loss drug - as it looks to launch the product across Europe.

GSK has approached a number of London agencies, with both roster and non-roster agencies being asked to tender.

The brief comprises digital and DM elements. Much of the initial work will be adapted from US advertising until such time as plans to launch the drug in Europe are given the go-ahead.

GlaxoSmithKline has already made inroads to get the product approved for sale in Europe, though under a different name. Last month, the European medicines regulator agreed to review a proposal for the drug's over- the-counter sale and respond next year.

This summer, Alli became the first weight-loss drug approved by the United States' Food and Drug Administration for sale over the counter. In the first five weeks after its launch, sales were more than £77 million.

GlaxoSmithKline did not return calls.

This article was first published on


You must log in to use Clip & Save

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Additional Information

Campaign Jobs